The FDA warning letters mostly went to cosmetic websites. In each case, the FDA said the companies were offering unofficial ...
The FDA approved linaclotide (Linzess) capsules to treat irritable bowel syndrome with constipation (IBS-C) in children age 7 ...
Investor's Business Daily on MSN
Biohaven Craters After FDA Unexpectedly Rejects Its High-Profile Drug
Biohaven stock cratered Wednesday after the FDA rejected the company's treatment for an inherited neurodegenerative disease.
A University of Manchester study reveals a drug approved for use in other conditions could be repurposed as a preventive ...
It is fair to say (no matter what else can be said) that the current administration is outcome- rather than process-driven. This general ...
FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, while safe, ...
Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback